2023
DOI: 10.3390/ijms242417224
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis B Virus and microRNAs: A Bioinformatics Approach

Verdiana Zulian,
Giulia Fiscon,
Paola Paci
et al.

Abstract: In recent decades, microRNAs (miRNAs) have emerged as key regulators of gene expression, and the identification of viral miRNAs (v-miRNAs) within some viruses, including hepatitis B virus (HBV), has attracted significant attention. HBV infections often progress to chronic states (CHB) and may induce fibrosis/cirrhosis and hepatocellular carcinoma (HCC). The presence of HBV can dysregulate host miRNA expression, influencing several biological pathways, such as apoptosis, innate and immune response, viral replic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 225 publications
0
1
0
Order By: Relevance
“…Despite some progress in understanding the pathological mechanisms and interventions of chronic liver diseases, effective biomarkers for predicting and preventing disease progression are still lacking. Diagnostic indicators often fail to accurately reflect the disease’s progression, and although several serum markers such as microRNAs ( 5 , 6 ), duplex-linear DNA ( 7 ), phospholipase A2 ( 8 ), Sirtuin 1 ( 9 , 10 ) show progressive elevation in chronic liver disease, they are not readily accessible, leading to increased costs associated with their assessment.…”
Section: Introductionmentioning
confidence: 99%
“…Despite some progress in understanding the pathological mechanisms and interventions of chronic liver diseases, effective biomarkers for predicting and preventing disease progression are still lacking. Diagnostic indicators often fail to accurately reflect the disease’s progression, and although several serum markers such as microRNAs ( 5 , 6 ), duplex-linear DNA ( 7 ), phospholipase A2 ( 8 ), Sirtuin 1 ( 9 , 10 ) show progressive elevation in chronic liver disease, they are not readily accessible, leading to increased costs associated with their assessment.…”
Section: Introductionmentioning
confidence: 99%